An Act to Institute
Maine Legislature, Session 132, LD 1847
Committee Amendment CA_C_H1045 (House)
Amends: 22 MRSA §2421-A, 22 MRSA §2423-A, 22 MRSA §2423-G, 22 MRSA §2423-H, 22 MRSA §2425-A, 22 MRSA §2429-A, 22 MRSA §2430, 22 MRSA §2430-J, 22 MRSA §2430-K, 22 MRSA §2430-P, 22 MRSA §2430-Q, 22 MRSA §2430-R, 28-B MRSA §102-A, 28-B MRSA §605, 28-B MRSA §1101, 36 MRSA §4921, 36 MRSA §4923

COMMITTEE AMENDMENT " ^" to H.P. 1231, L.D. 1847, "An Act to Institute
Testing and Tracking of Medical Use Caimabis and Cannabis Products Similar to Adult
Use Canaabis and Cannabis Products, Dedicate a Portion of the Adult Use Cannabis Sales
and Excise Tax to Medical Use Cannabis Programs and Create a Study Group"
Amend the bill by striking out the title and substituting the following:
'An Act to Institute Testing and Tracking of Medical Use Cannabis for Large
Registered Dispensaries, to Institute Mandatory Annual Inspections and Sample
Testing in the IVIaine Medical Use of Cannabis Act, to Amend the Excise Tax
Provisions for Adult Use Cannabis for Cannabis Pre-rolls and to Make Other
Changes to the Mfedical Use and Adult Use Cannabis Programs'
Amend the bill by striking out everything after the enacting clause and insertmg the
following:
'PART A
Sec. A-l. 22 MRSA §2421-A, sub-§l-A is enacted to read:
1-A. Batch. "Batch" means a soecific Quantity of cannabis flower, cannabis trim.
cannabis concentrate or cannabis products harvested or manufactured at the same time
under the same conditions using the same process or orocedure.
Sec. A-2. 22 MRSA §2421-A, sub-§3-A is enacted to read:
3-A. Canaabis flower. "Caimabis flower" means the mstillate reproductive organs of
a mature cauaabis olant. whether orocessed or unorocessed. including the flowers and buds
of the plant. "Cannabis flower" does not include cannabis trim or whole mature cannabis
plants or the flower of hemp as defined in Title 7, section 2231. subsection ^
D_
Sec. A-3. 22 MRSA §2421-A, sub-§6-A is enacted to read:
6-A. Cannabis pre-roll. Cannabis ore-roll" means cannabis flower, caimabis trim
or a combination of cannabis flower and cannabis trim that is rolled m rolling papers.
COMMITTEE AMENDMENT
COMMHTEE AMENDMENT"^/ to H.P. l231,L.D. 1847
ciearette papers or wraps. with or without a cardboard filter, and intended for smokine. A
carmabis pre-roll may be infused with carmabis concentrate.
Sec. A-4. 22 MRSA §2421-A, sub-§8, as enacted by PL 2023,c. 679,Pt. A,§3,is
repealed and the following enacted m its place;
8. Cannabis testing facility. "Cannabis testina facility" means a facility registered in
accordance with section 2425-A or a facility licensed under Title 28-B. chapter 1 to operate
a testing facility.
Sec. A-5. 22 MRSA §2421-A, sub-§9-A is enacted to read;
9-A. Cannabis trim. "Cannabis trim" means any p_art of a caBnabis olant. whether
processed, or unDrQcessecL that is nQtcannabis flower or a cannabis seed. exceot that
"caunabis trim" does not include the stalks or roots of the cannabis plant. "Cannabis trim"
does_not^clu^e any parLoJa h^ defmed m Title 7. section 2231. subsection
l-A.uaraeraohD.
Sec. A-6. 22 MRSA §2421-A, sub-§24-A is enacted to read:
24-A. Large reeistered dispensarv. "Large registered disoensarv" means a registered
disuensary as defined under subsection 41 with a mature plant canonv of 2.000 sauare feet
or more.
Sec. A-7. 22 MRSA §2421-A, sub-§27-A is enacted to read:
27-A. Matrix. "Matrix" means, as applicable to the testina of harvested caimabis. the
form in which harvested camiabis exists at the time it is subject to mandatory testing in
accordance with this chauter. Matrix includes the followine cateeories of harvested
cannabis:
A. Carmabis flower and carmabis trim. mcludine cannabis ore-rolls:
B. Cannabis concentrate, includmg concentrates extracted using solvents, as well as
SQlventless_extractiQninethods; and
C. Cannabis product.
Sec. A-8. 22 MRSA §2421-A, sub-§42, as enacted by PL 2023,c. 679,Pt. A, §3,
is amended to read:
42. Registrant. "Registrant" means a registered caregiver, dispensary, including a
large registered dispensarv. cannabis testing facility, manufacturing facility or person
authorized to engage in cannabis extraction using inherently hazardous substances under
this chapter.
Sec. A-9. 22 MRSA §2421-A, sub-§43, as enacted by PL 2023,c.679,Pt. A, §3,
is amended to read:
43. Registrant agent. "Registrant agent" means an assistant, employee, officer,
director or other authorized agent of a registered caregiver, dispensary, mcludine a large
registered dispensarv. cannabis testing facility, manufacturing facility or person authorized
to engage in cannabis extraction using inlierently hazardous substances under this chapter.
Sec. A-10. 22 MRSA §2421-A, sub-§45-A is enacted to read:
Page2-132LR0854(04)
COMMITTEE AMENDMENT
COMMHTEE AMENDMENT "/' " to H.P, 1231, L.D. 1847
45-A. Remediation. "Remediatioii" means the orocess bv which a reeistrant mitieates
or otherwise removes a contaminant from a batch of harvested cannabis that failed
mandatory testing due to the presence of that contaminant, "Remediation" includes without
Hmitflrinn the application of heat. radiation, or ozone; solvent extraction; or further drying
and curine. Remediation" does not include the dilution of contaminants tfarough the
addition of uncontammated material to batches of harvested cannabis that are
contaminated.
Sec. A-ll. 22 MRSA §2421-A, sub-§51-A is enacted to read:
51-A. Testing or test. "Testme" or "test" means the analysis of harvested cannabis or
other substances for contaminants. safety or uotencv. "Testine" or "test" includes the
collection of samples of harvested carmabis for testing ourposes but does not include
cultivation or manufacturine.
Sec. A-12. 22 MRSA §2421-A, sub-§51-B is enacted to read:
51-B. THC. "THC" means tetrahvdrocamiabinol.
Sec. A-13. 22 MRSA §2423-A, sub-§10, as amended by PL 2025,c.390, Pt. A,
§38 and c. 611, §3, is repealed.
Sec. A-14. 22 MRSA §2423-A, sub-§12, as repealed and replaced by PL 2019, c.
331, §15 and amended by PL 2021, c. 669, §5, is repealed.
Sec.A-15. 22 MRSA §2423-G is enacted to read:
S2423-G. Testine proeram established; laree reeistered disoensaries
The^ office^hall establish a testine oroeram for harvested caimabis fi-omlarge registered
disnensaries.
1. Testing required. The testing proeram must require a large registered dispensary.
prior to sellina. distributing or transfemne harvested cannabis to a aualifyine patient or to
an individual on behalf of a aualifvtns uatient. to submit the harvested canaabis to a
caunabis testma facility for testing to ensure that the harvested cannabis does not exceed
the maximum level of allowable contamination for any contaminant that is iniurious to
health and for which testing is reauired and to ensure accurate labeling.
2. Rules. The office shall adopt rules establishine a testing program uursuant to this
0 section, mcludmg, but not limited to;
A. Rules identifying the tvoes of contaminants that are iniurious to healfh for which
2 harvested cannabis must be tested under this chapter and rules regarding the maximum
3 level of allQwable_contammatiQn for each identified CQntammant;
B, Rules establishing testine and maximum level parameters for soeciation testing of
5 harmful veasts and molds, includme the range for allowine soeciation tests for cannabis
6 flower and cannabis trim testing, which must be set based on evidence-based wactices;
and
C. Rules establishing testing orotocols that ensure consistent and accurate reportmgpf
potency.
Rules adopted pursuant to this subsection are routine technical rules as defined in Title 5.
chapter 375, subchapter 2-A,
COMMITTEE AMENDMENT
COMMnTBEAMENDiMENT"r "toH.P. 1231, L.D. 1847
Sec.A-16. 22 MRSA §2423-H is enacted to read:
82423-H. Cannabis testine facilities: requirements
1. Facility requirements. The followine requirements^e apBUcableJo &
of a cannabis testine facility registered in accordance with this chapter reaardmg mandatory
testing and other testine of harvested caimabis.
A. A testing facility that is licensed pursuant to Title 28-B. chapter 1 to test cannabis
and cannabis products for harmful contaminants and cannabmoid orofiles may be
issued a registration certificate to operate a cannabis testine facility under this chapter.
as lone as the licensed testing facility is in good standing with the office and the reauest
for a reeistration certificate is submitted on forms provided by the office. There is no
fee for a reeistration certificate issued to a testing facility licensed under Title 28-B.
chapter 1. All emulovees of the cannabis testine facilifry that conduct mandatory and
other testing on harvested cannabis shall obtain from the office a registry identification
card in accordance with section 2425-A,
B. A person that is not licensed under Title 28-B. chapter 1 to operate a testine facility
may auolv for a registration certificate to operate a cannabis testing facility j.mder this
chapter m accordance with the requirements of section 2425-A. The office may not
issue a resistration certificate to a person mu-suant to this oaraeraoh and section 2425-A
unless the apolicant also demonstrates that:
d) The anulicant has obtained accreditation pursuant to standard ISO/D3C 17025
of the International Organization for Standardization by a 3rd-r>artv accreditine
body for all fields of mandatory testing, in all matrices, required under this chapter:
(2) The aoolicant has obtained certification, by the Maine Center for Disease
Control and Prevention in accordance with section 569 for all fields of mandatory
testme. in all matrices. required underfhi's_chaoter;
(3) The applicant and. if the aoolicant is a business entity, anyone with a financial
or other interest in the annlicant is not a careeiver. a registered careeiver or an
officer or director of a registered dispensarv or manufacturine facility; and
(4) The aBBlicant has obtained local authorization in accordance with section
2429-D from the municipality where the cannabis testine facility will be located.
C. For the purposes of administerme tests pursuant to this chapter, a registered cannabis
testine facility is authorized to:
fl) Accept and possess samples of harvestecLcannabis for mandatorv testing from
registrants;
(2} Accept and possess samples of harvested camabis for other testina from
registrants, aualifymg patients and members of the public;
(3) Test samples of harvested carmabis for mandatory and other testing and report
8 the results of such testing to the registrant. aualifvme patient or member of the
public that submitted the samples for testins:
(4) Reuort the results of any mandatory and other testine conducted pursuant to
fhjs chapter to the office;
Page4-132LR0854(04)
COMMITTEE AMENDMENT
COMMnTEE AMENDMENT"/" "toH.P. 1231,L.D. 1847
f5) Test samples of harvested caimabis that are submitted for retestine after a failed
mandatory test and report the results ofretestine to the registrant, aualifsdng patient
or member of the public that submitted the samples for retesting and to the office;
and
C6) Hire any number of cardholders necessary to conduct analYses in accordance
with this chapter.
2. Rules. The office may adopt rules reeardine the reeistration. certification.
accreditation and operation of camiabis testing facilities authorized under' tUs_ch^^
mcludme. but not limited to. mles establishine acceptable testine oractices for caimabis
testing facilities, including, but not limited to. provisions relating to testing practices.
methods and standards; remediation and retesting procedures: quality control analysis:
equipment certification and caUbrationLcherMc^^^^^^ cannabis testing facility
record-keemne. documentation and business uractices: disposal of used. unused and waste
harvested cannabis; andreportine of test results. The office shall, to the extent practicable,
establish pass and fail requirements for carmabis testing in accordance with auolicable
national and international quality standards established for botanical mgredients_by the
American Herbal Pharmacopoeia. the United States Pharmacopeia; the European
Phannacopoeia and the British Pharmacopoeia or successor oreanizations, Rules adopted
pursuantto this subsection are routme technical rules as defined in Title 5. charrter 375.
subchauter 2-A. The office may. alternatively, require carmabis testme facilities repistered
pursuant to this chapter to comply with any rules and standards established for testing
facilities licensed under Title 28-B. chapter 1.
Sec. A-17. 22 MRSA §2425-A, first ^ as enacted by PL 2017, c. 452, §12 and
amended by PL 2021, c. 669, §5, is further amended to read:
This section governs registry identification cards and registration certificates, except
that registration of manufacturmg facilities and persons authorized to engage in cannabis
extraction is governed by section 2423-F and registration of cannabis testing facilities is
governed by section 2^123 A, subsection 10 2423^H.
Sec. A-18. 22 MRSA §2425-A, sub-§2, as enacted by PL 2017, c. 452, §12, is
amended to read:
2. Required registration. A caregiver, other than a caregiver operating under section
2423-A, subsection 3, paragraph C, and an officer or director or assistant of a dispensary
or a caregiver registrant, other than a caregiver operating under section 2423-A, subsection
3, paragraph C, shall obtain a registry identification card in accordance with subsections 3,
4 and 5. A long-term care facility designated by a qualifying patient pursuant to section
2423-A, subsection 1, paragraph F-l, subparagraph (2) and a dispensary or a cannabis
testing facility shall obtain a registration certificate in accordance with subsections 6,7 and
8.
Sec. A-19. 22 MRSA §2425-A, sub-§6, as amended by PL 2025, c. 611, §7, is
further amended to read:
6. Application for registration certificate; qualifications. The department office
shall register and issue a registration certificate to an applicant who submits a complete
application that meets the requirements of this subsection.
COMMITTEE AMENDMENT
COMMTTTEE AMENDMENT "/-> "toH.P, 1231, L.D. 1847
The dopurtmont office shall conduct a criminal history record check pursuant to section
2425-B for each officer or director of the applicant for a registration certificate. The
department office may not issue a registration certificate to an applicant if any officer or
director of the applicant has been convicted of a disqualifying dmg offense.
An application must include, as applicable:
A. The annual fee required pursuant to subsection 10;
B. Evidence of the applicant's registration with the Secretary of State and evidence
that the applicant is in good standing with the Secretary of State; aad
C. The name, address and date of birth of each officer or director of fhe applicant-;
D. For applicants for a dispensarv registration certificate, plans for compliance with
the requirements of section 2428: and
E. For applicants for a caimabis testing facility registration certificate, demonstration
that the applicant is in compliance with the requirements of section 2423 -H.
Sec. A-20. 22 MRSA §2429-A, sub-§l, ^C, as enacted by PL 2017, c. 452, §18
and amended by PL 2021,c.669,§5, is further amended to read:
C. Packaged in a container with an integral measurement component and child-
resistant cap if the carmabis product is a multiserving liquid; a&d
Sec. A-21. 22 MRSA §2429-A, sub-§l, ^C-l is enacted to read:
C-1. For large reeistered disoensaries. packaged in a^aimer_that does not introduce
harmful contaminants to the harvested cannabis after it has passed mandatory testme
required under this chapter; and
Sec. A-22. 22 MRSA §2429-A, sub-§3, as enacted by PL 2017,c. 452, §18 and
amended by PL 2021, c. 669, §5, is further amended to read:
3. Labels. If a registered caregiver, dispensary or manufacturing facility affixes a
label on the packaging of any harvested cannabis provided to a qualifying patient and that
label includes information about contaminants, the cannabinoid profile or potency of the
harvested cannabis, the label must be verified by a carmabis testing facility. This subsection
does not apply if there is no carmabis testing facility operating in accordance with section
2^123 A, ouboootion 10 2423JH.
See. A-23. 22 MRSA §2430-1, sub-§l-A, ^[A, as enacted by PL 2023, c. 679, Pt.
A,§26, is amended by enacting a new subparagraph (4-A) to read:
C4-A') Intentionally or knowinglv failing to conduct a recall of harvested cannabis
or carmabis oroducts when reauired to do so bv the office;
Sec. A-24. 22 MRSA §2430-1, sub-§l-A, ^B, as enacted by PL 2023, c. 679, Pt.
A, §26, is amended by enacting a new subparagraph (9-A) to read:
f9-A) Exceeding the maximum level of allowable contamination for residual
solventsor pesticides m a samnle of harvested cannabis collectecLand tested imder
section 2430-S. subsection 4. paraeranh B:
Sec. A-25. 22 MRSA §2430-1, sub-§l-A, ^C, as enacted by PL 2023, c. 679, Ft.
A, §26, is amended by enacting a new subparagraph (3-A) to read:
COMMITTEE AMENDMENT
COMMITTEE AMENDMENT "^ "toH.P. 1231,L.D. 1847
'c
f3-A~) Exceed the maximum level of allowable contamination for residual solvents
or pesticides in the initial sample collected by the office during a mandatorv amiual
inspection pursuant to section 243 0-K. subsection 2-A and tested pursuant to
section 243 0-S:
Sec. A-26. 22 MRSA §2430-J, as enacted by PL 2023,c. 365,§21, is repealed and
the following enacted m its place:
82430-J. Records; reporting; labels; inventory tracking mfQrmation
The office shall develop. implement and maintam a statewide electronic portal throueh
which registered careeivers. registered disoensaries. other than laree regiMered
dispensaries. cannabis testitte facilities and manufacturing facilities may submit to the
office the records required pursuant toJhis^haBteLThe office may not reauire records
submitted through the portal to contain information identifvmgjmali&mg mtients or their
medical providers.
The office shall also implement and administer a statewide inventory tracking system
throueh which large registered disoensaries. uursuant to subsection 3. are required to
submit to the office the electronic records required pursuant to this chaBter, Large registered
disoensaries shall pay all costs and fees associated with the use of the inventory trackine
system and all other costs associated with the keeping of records required in this section,
The office may not require records maintained in the inventory tracking system to contain
infoimation identifying qualifying patientsor their medical providers.
1. Required records. A reeistered careeiver. a registered dispensarv. other than a
large registered dispensary. a cannabis testing facility and a manufacturine facility shall;
A. Maintain records related to the authorized conduct of the registered careeiver. the
registered dispensary. the camiabis testing facilifrv and the manufacturing facility that:
d) Are specific to the types of authorized activity being conducted;
(2) Disclose all authorized conduct and all transactions of the registrant m enough
detail for the office to be able to conduct an audit for compUance;
f3) Are inclusive of the time oeriod from uurchase or acauisition of cannabis olants
and harvested camiabis throueh anv manufacture, transfer, sale or transoort of the
cannabis plants or harvested cannabis:
(4) Can be used to trace the camiabis plants and harvested cannabis back to the
registrant where the cannabis plant or harvested cannabis oriemated:
(5) Include documentation of the batch number on any cannabis plants and
harvested cannabis received or the batch number assigned by the registrant to anv
carmabis plants or harvested carmabis cultivated, harvested or manufactured by the
registrant;
(6} Include documentation of any batch numbers from any cannabis plants or
8 harvested carmabis that is used to create a new batch; and
(T) Include sufficient detail to be able to conduct a recall of any cannabis plants
and harvested caimabis as needed.
For the^ DiusQses_of^this pa.ragrai:!h. "batch number" means a distmctgroup of numbers,
letters or SYmbols^or^n^cQm^ thereof, assiened to a specific batch of harvested
COMMITTEE AMENDMENT
COMMTTTEE AMENDMENT "r "toH.P. 1231,L.D. 1847
u
cannabis by a registered careeiver. registered disDensarv. cannabis testme facility or
manufacturing facility;
B. Keep the records for a neriod of 4 years: and
C, Make the records maintained under this subsection available for inspection by the
office upon the office s reauest,
2. Required label. A registered careeiver. reeistered disoensarv. other than a laree
registered disoensarv, cannabis testine facility and manufacturing facility shaU accomoanv
all cannabis plants and harvested cannabis being transported pursuant to this chapter with
a label that identifies:
A, The person transfemne the cannabis olants or harvested cannabis. mcludme the
persons registry identification number;
B. The person receivmg the cannabis plants or harvested cannabis. mcludine the
person's registry identification number or. if the person is not required to reeister under
this chauter. a uniaue identifier assigned to the nerson;
C. A descriution of the cannabis plants or harvested cannabis beine transferred.
including the amount and form:
D. The time and date of the transfer: and
E. The destination of the cannabis plants or harvested cannabis.
The department may adopt mles to unolement this subsection. Rules adopted pursuant to
this subsection are major substantive mles as defined in Title 5. chapter 375. subchapter
2-A.
3. ^Laree reeistered di^Bens^an^^ records: inventory trackine
information. A large registered dispensarv shall keep. for a period of 6 years, a record of
all cannabisplants and harvested cannabis from immature cannabis plant to the ooint of
sale or transfer to a aualifvine patient retjm. disposal or destruction.
Large repistered dispensaries shall submit to the office by 11:59 o.m. every day the
followme mformation through the inventory trackine system:
A. A complete inventory of all caimabis plants and harvested carmabis cultivated.
manufactured, stored or otherwise within the possession or control of the large
registered disoensary;
B. A record of all transfers of carmabis plants or harvested cannabis transferred to or
from the large registered disoensarv that includes, at a mmimum:
(D The oerson transfen'me the catinabis nlants or harvested camiabis. includine
the person's registry identification number:
(2) The person receiving the cannabis plants or haryested cannabis, mcluding the
person's regisfry identification number or. if the person is not required to register
under this chapter, a unique identifier assigned to the person.
A registrant transferring cannabis plants or harvested cannabis to a person who is
not required to reeister under this chauter shall mamtain and uroduce to the office
upon reQuest a list that itaLtifies the imiaue identifier and the person to whom that
identifier is assigned:
COMMITTEE AMENDMENT
COMMITTEE AMENDMENT " ^ " to H.P. 1231, L.D. 1847
c"
(3} A description of the cannabis plants or harvested caimabis beine transferred.
includine the amount and form:
C4) The time and date of the transfer: and
f5) The destination of the cannabis plants or harvested cannabis; and
C. A record of all mandaton/ test results for each batch of harvested cannabis offered
to aualifvina oatients.
This subsection may not be construed to require a large registered dispensarv to resubmit
mventorv trackine information to the office if no changes have been made to the inventory
maintained by the large registered dispensary. The office may adopt mles to implement this
subsection, including, but not limited to, rules regarduig the process and content of records
to be submitted and the frequency with which records must be submitted, as well as mles
regarding enforcement of the inventory tracking requirements of this chapter. Rules
adopted pursuant to this subsection are routine technical rules as defined in Title 5, chapter
375. subchapter 2-A.
Sec. A-27. 22 MRSA §2430-K, as enacted by PL 2023,c.365, §22, is amended to
read;
§2430-K. Inspections; limitation
The office shall conduct annual mspections of registered carepivers, registered
disuensaries. other than large repistered disoensaries. and manufacturine facilities in
accordance with this section. section 2430-S and rules adopted pursuant to this chauter.
The department office may conduct inspections of registered caregivers, registered
dispensaries, cannabis testing facilities and manufacturing facilities in accordance with this
section and rules adopted pursuant to this chapter. The department office may not conduct
an inspection of a qualifymg patient or caregiver operating under section 2423-A,
subsection 3, paragraph C.
1. Criteria. The department office shall maintain a publicly accessible electronic
version of the criteria for inspection of registered caregivers, registered dispensaries,
carmabis testing facilities and manufacturing facilities.
2. Access to premises. Notwithstanding any provision of law to the contrary, to ensure
compliance with this chapter or in response to a complaint, the department office may
inspect the premises where a registered caregiver, registered dispensary, caimabis testing
facility or manufacturing facility conducts activity authorized under this chapter, without
notice during regular business hours or during hours of apparent activity, except that the
department office may not enter the dwelling unit of a registered caregiver if the registered
caregiver is not present and may inspect fhe area of a dwelling unit only where activity
authorized under this chapter occurs.
7 2-A. Annual inspection; sample collection; mandatory testine. During the amiual
inspection required under this section for reeistered careeivers. reeistered dispensaries.
other than large registered dispensaries. and manufacturins facilities, the office shaU collect
a sample from haaestedcar^ a registered careeiver,
registered disoensarv. except a laree registered disoensarv. or manufacturing facility
conducts activity authorized under this chapter. The office shall conduct testine on the
sample in accordsnc-e-wi&sectiQn^^^
COMMITTEE AMENDMENT
COMMTTTEE AMENDMENT"/- "toH.P. 1231, L.D. 1847
3. Complaints. If the department office conducts an inspection in response to a
complaint, the department office shall provide the registered caiegiver, registered
dispensary, cannabis testing facility or manufacturing facility subject to the inspection a
written statement of the substance of the complaint at the time of the inspection.
4. Contamination prevention. The department office shall develop and post on the
department's publicly accessible website guidance on how a person conducting inspections
under this section can prevent contaminating the premises being inspected,
5. Notification of unauthorized conduct. If during an inspection the department
office finds evidence of a violation of this chapter or rules adopted pursuant to this chapter,
the dopartmont office shall, within one business day of the completion of the inspection,
provide written notification of the identified violation to the registered caregiver, registered
dispensary, cannabis testing facility or manufacturing facility. Notice under this subsection
does not constitute final agency action.
6. Penalty. In addition to any other penalty authorized under this chapter, tiie registry
identification card or registration certificate of a registered caregiver, registered dispensary,
cannabis testing facility or manufacturing facility that refuses or willfully avoids 2 or more
inspections under this section may be suspended or revoked pursuant to section 2430-1 or
the department office may refuse to renew the regisby identification card or registration
certificate.
Sec.A-28. 22 MRSA §2430-0 is enacted to read:
§2430-0. IMaadatorv testine; large reelstered dispensaries
A large registered dispensary may not sell. distribute or transfer harvested cannabisto
a aualifvine uatient or to an individual on behalf of a aualifyine patient unless the harvested
cannabis has been tested pursuant to this chauter and that testing demonstrates that the
harvested cannabis does not exceed the maximum level of allowable contamination for any
contaminant for which testing is required, as anolicable, based upon fhe matrix in which
the harvested carmabis is intended to be used by a aualifvine uatient. The office may require
testing for some analvtes in some matrices before the harvested cannabis is further
processed, manufactured or combined to ensure tliat contaminants that_are iniuriQus to
health do not contaminate other batches of harvested cannabis. All cannabis concentrates
used to manufacture carmabis products in accordance with this chapter must be tested in
accgrdance with subsection 3 or 4 urior to being used to manufacture a cannabis product
or a cannabis ore-roll inftised with cannabis concentrate.
The office may temporarily waive mandatory testine requirements under this section
for any contaminant or 'factor for which the office has determmed that there exists no
cannabis testing facility in the State capable of and authorized to uerform such testing.
1. Scope of mandatory testine eenerally. Mandator/ testina of harvested cannabis
8 under this sectionmustinclude, but isjiot limited to, testing for:
A. Residual solvents, poisons and toxins:
B. Metals;
C. Daueerous molds and mildew. includine. but not litoited to. Asoersillus soo. and
mvcotoxms,_as aDplicablei
D, Harmful microbes, includine. but not limited to. Escherichia coli and Salmonella:
COMMITTEE AMENDMENT
COMMHTEE AMENDMENT"/^ "toH.P. 1231,L.D. 1847
E. Pesticides, fimeicides and insecticides:
F, Water activity, for harvested cannabis except cannabis concentrate: and
G. THC Dotencv. homoeeneitv and caimabinoidDrofiles.
2. Scope of mandatory testine for cannabis flower and cannabis trim. Cannabis
flower and cannabis trim. including canuabis ore-rolls and caimabis flower or cannabis trim
that has been mixed with cannabis concentrate, must be tested for:
A. Metals;
B. Dangerous molds and mildew. includmg. but not limited to. Aspergillus spp. and
mvcotoxins, as applicable. Testme for mvcotoxms is mandatQrv if the batch fails
mandatory testing for dangerous molds and mildew and is subsequently retested;
C. Harmful microbes;
D. Pesticides, funeicides and insecticides;
E, Water activity: and
F. THC tiotencv and camiabinoid orofiles.
3. Scope of mandatory testing for camiabis concentrate extracted usine solvents
other than water. Cannabis concentrate that has been extracted using solvents ofher than
water must be tested for:
A. Residual solvents, uoisons and toxins;
B. Metals;
C. Pesticides, funeicides and insecticides;
D. Mvcotoxins: and
E. THC potency, homogeneitv and camiabmoid profiles.
4. Scope of mandatory testine for cannabis coacentrate extracted^^^w^ use of
solvents other than water. Cannabis concentrate that has been extracted without the use
of solvents other than water must be tested for:
A. Metals;
B. Dangerous molds and mildew. mcludine. but not limited to. Aspereillus spp. and
mvcotoxins. as aoulicable. Testine for mvcotoxins is mandatory if the batch fails
maadator/ testing for dangerous molds and mildew and is subsequently retested;
C, Harmful microbes;
D, Pesticides, funeicides and insecticides: and
E. THC ootencv. homoeeneitv and cannabinoid profiles,
5. Scope of m^a^ Cannabis products, mcludine
edible cannabis products, must be tested for;
A, Daneerous molds and mildew. includme. but not limited to. Asoereillus SDD. and
mvcotoxins. as applicable. Testme for mvcotoxins is mandatory if the batch fails
mandatory testing for dangerous molds and mjldew and is subsequently retested;
B, Harmful microbes;
COMMITTEE AMENDMENT
COMMnTEE AMENDMENT"/^ "toH.P. 1231,L.D. 1847
'&'
C. Water activity, except that edible cannabis products that are preserved by
refiigeration are not required to be_testeclfor water actiyitv; and
D. THC ootencv. homoeeneitv and cannabinoid profiles.
6. Record keepine. A large registered dispensarv shall maintain a record of all
mandatory testing that includes a description of the harvested cannabis provided to the
cannabis testine facility, the identity of the caimabis testing facility and the results of the
mandatory test. The results of all mandator/ tests conducted by a cannabis testine facility
must be recorded in accordance _with the record-keepmg and inventory tracking
reauirements of section 2430- J.
7. Sample collection, testme processes, protocols and standards. The office may
establish by mle processes, protocols and standards for the cQUection of samples for
mandatory testine and for the mandator/ and other testing of harvested cannabis that
conform with the best practices generally used to sample the awlicable matrices and test
for the presence or absence of the contaminants identified in this section basecLupon the
matrix of the harvested cannabis tested. The rules may include an allowable variance rate
for detennimne the amount or potency of THC or other caimabinoids in edible caonabis
products. The office shall, to the extent practicable, establish, pass and fail requirements for
cannabis testing in accordance with applicable national and international quality standards
established for botanical ingredients by the American Herbal Pharmacoooeia. the United
States Pharmacooeia. the European Phannacoooeia and the British Pharmacouoeia or
successorjirgamzations^ Rules_adop^ p^ to this subsection are routmejechnical
rules as defined in Title 5. chapter 375. subchaoter 2-A. The office may. alternatively.
require registrants to comply with any rules and standards established for testing canaabis
under Title 28-B. chapter 1.
8. Maximum batch size for mandatory testing. For the tiurpose of samriline and
mandatory testine under this section, a batch may not exceed 44 pounds by net weisht.
regardless of matrix.
A. For carmabis flower and cannabis trim. includine cannabis pre-rolls. the 44-pound
limit appUes to the combined net weight of carmabis flower or cannabis trim harvested
or manufactured at the same timeunder the same conditions usinfi the_same urocess or
procedure.
B, For cannabis concentrate and cannabis products, the 44-pound limit applies to the
3 combined net weight of the fimshed material in that matrix that is manufactured at the
same time under the same conditions using the same orocess or Drocedure.
5 The office may adopt mles for sample collection that ensure representative sampling within
6 the 44-oound maximum batch size iu accordance wi&subsection TJ^ules adopted Rursuant
to this subsection are routine technical rules_as defined in Title 5. chaoter 375. subchaoter
2-A.
Sec.A-29. 22 MRSA §2430-P is enacted to read:
§2430-P. Notification requirements
1. Notification of testing results required. If the results of a mandatory test
conducted pursuant to section 2430-0 indicate that the harvested cannabis exceeds the
maximum level of allowable contamination for any contaminant that is injurious to health
and for which testing is required, the canriabis testing facility shall immediately notify the
COMMITTEE AMENDMENT
COMMirTEE AMENDMENT"/^ "toH.P. 1231, L.D. 1847
u
office and the laree reeistered disDensary that submitted the samules for mandatory testine
of the failed test, If a large registered disoensary successfully undertakes remediation and
retestine of harvested cannabis. the cannabis testine facility shall notify thejoffice of the
subsequent passed mandatory testine.
2. Notification of testme results not reaujred. A caimabis testing facilitv is not
required to notify the office of the results of any test conducted on:
A. Harvested cannabis at fhe direction of a large reeistered disoensarv oursuant to
section 2430-0 that demonstrates that the harvested cannabis does not exceed the
maximum level of allowable contamination for anv contaminant that is iniurious to
health and for which testing is required:
B. Harvested cannabis at the direction of a registered careeiver. disoensarv or
manufacturing facility for research and develoBmenLQurposes onlv. as long as the
registered careeiver. dispensar/ or manufacturme facility notifies the carmabis testme
facility prior to the oerfbnnance of the test that the testine is for research and
develooinent ouTDOses onlv;
C. Harvested caimabis at the direction of a person who is not a registered caregiver.
dispensary or manufacturing facility; or
D. A substance that is not harvested cannabis,
Sec.A-30. 22 MRSA §2430-Q is enacted to read:
82430-0. Sample coUection for testiae
1. Sample coUectine rules. A large registered dispensary. a sample collector licensed
pursuant to Title 28-B, chapter 1 or an emulovee of a sample collector or cannabis testing
facility may collect samples of harvested cannabis for mandatory testine. The office may
adopt mles reeardine the collection of samples of harvested cannabis for mandatory_testmg
by a laree registered dispensarv. a samule collector licensed pursuant to Title 28-B, chaDter
1 or an emDloyee of a sample collector or cannabis testmg facility, which may mclude. but
are not limited to:
A. Establishment of samule collecti&e orocesses. orotocols and standards. which must
be comRlied^ with bv any person collectine samples of harvested cannabis for
man.datorv testing purposes:
B. Requirements for a large registered disuensarv to demonstrate that the sample
collector s sample collectine oractices comulv with uaraeraDh A;
C. Provisions authorizing the office to conductjnidits_Qf haryested cannabisthat was
tested using samples collected by a laree registered dispensarv pursuant to this section.
with all costs of the audits to be paid for by the large registered dispensarv subiectto
an audit of that sample collector's sample collecting practices;
D. Provisions authorizine the office to take samoles of harvested cannabis fi'om a laree
registered dispensar/. including from a retail location maintained by the large
registered dispensary. for testing by a cannabis testing facility to audit or verify
mandatory test results issued by the cannabis testing facility. wifh all costs of the testine
to be paid for by the large registered disoensarv:
COMMITTEE AMENDMENT
COMMmEE AMENDMENT"/- "toH.P. 1231,L.D. 1847
E, Provisions authorizine the office to conduct interlaboratorv oroficiencv testing to
ensure cannabis testing facility comuliance with testing program requirements and to
ensure the quality, consistency and reliability of mandatory testing conducted_by
cannabis testine facilities authorized pursuant to this chapter:
F. Requirements for the transportation, deUvery^nd transfer of samples of harvested
cannabis collected by a laree registered disoensar^ to a cannabis testine facility, which
must require the m-oerson transfer of the samules by the large resistered discensarY^to
a cannabis testing facility; and
G. A prohibition on the intentional tamuerine with or interference in the mandatory
testing process or auditine process, includine failure of any audit conducted in
accordance with oaraeraoh C, by a large registered dispensarv. which, notwithstandme
any orovision of this chapter to the contrary, may be treated by the office as constitutins
a violation oforoeram requirements and as a basis for imposition of a penalty uursuant
to section 2430-1. subsection 2, as applicable.
2. Samples for investieation. This section may not be constmed to limit the authority
of the office to take samples of harvested cannabis pursuant to an investieation bv the office
into the conduct of a registrant or a reeistrant agent,
3. Rules. Rules adopted pursuant to this section are routine technical rules as defined
mTjtle 5. chapter 375. subchaoter 2-A.
Sec.A-31. 22 MRSA §2430-R is enacted to read:
S2430-R. Additional testine not required
Notwithstandine section 2430-0. a large registered disoensar/ may sell. transfer or
otherwise furnish to a aualifvine patient or careeiver or to another reeistered caresiver.
assistant of a registered careeiver. disuensarv or manufacturing facility harvested cannabis
that the large registered dispensary hasjiot submitted_fQr testine inaccQrdancewith this
chapter if:
1. Prior testing. The harvested cannabis has previouslY undergone all required testine
in accordance with fhis chapter at the direction of another large registered disoensarv and
that testing demonstrated that the harvested cannabis does not exceed the maximum level
of allowable contamination for any contaminant that is injurious to health and for which
testing is required;
2,_ProDer documentation. The mandatory testing process and fhe test results for the
harvested cannabis are documented in accordance with the requirements of this chapter;
3. Trackine maintained. Trackine fiom immature cannabis plant to the ooint of sale
or transfer to a qualifying patient, or another individual on behalf of a aualifvine oatient.
has been maintained for the harvested cannabis and transfers of the harvested cannabis to
another registered caregiver, assistant of a registered careeiver. dispensary or
manufacturine facility or to a aualifvine patient or careeiver on behalf of a aualifvine
patient can be readily identified: and
4, No further processine, manufacturme or alteration. Since the performance of
the Drior testine under subsection 1. the harvested cannabis has not 'midereone anv further
processing, manufacturing or alteration other than the packaging and labeling of the
harvested cannabis in accordancewithJhis chapter. For fhe purposes of_this subsection.
COMMITTEE AMENDMENT
COMMm-EE AMENDMENT"/-' "toH.P. 1231,L.D. 1847
further processme. manufacturing or alteration" does not include the use of cannabis
concentrate in the creation of an edible caimabis wodiLct^except for testing under section
2430-0. subsection 5. paragraph D.
Sec.A-32. 22 MRSA §2430-8 is enacted to read:
S2430-S. Annual inspections; mandatory sample testme
The office shall conduct testing of samples collected during the annual inspection
required under section 243 0-K for registered careeivers, registered dispensanesi, pther than
large registered disoensaries. and manufacturing facilities in accordance with this section,
This section may not be constmed to limit the authority of the office to take samples of
harvested cannabis pursuant to an mYestigation by the office into the conduct of a registrant
or a registrant aeent,
1. Mandatory testine; costs. The_Qffice__shall test a sample of harvested cannabis
collected under this section for:
A. Residual solvents;
B. Metals:
C, Molds and mildew: and
D. Pesticides.
The costs associated with conductine tests under this subsection must be paid for by the
registered careeiver. reeistered dispensarv. other than a large reeistered disDensarv. and
manufacturmg facUitv fi'om which the sample was coUected,
2. Other testine; costs. The office may conduct other tests on a sample of harvested
cannabis collected under this section for the purpose of research and data collection. Any
test conducted under this subsection must be paid for by the office.
3. Notification of results: records. The office shall notify a registered careeiver.
registered disoensarv. other than a large registered disoensary. and manufacturing facilitv
within one business day of the office receiving the results of any test conducted under this
section. The office shall provide a written copy of any test results with the notification, A
resistered careeiver. reeistered disoensarv. other than a laree reeistered disoensarv. and
manufacturing facility shall keep a record of all test results under this section for a period
of 4 years in the same manner as other records reauired to be keot under this chaoter.
4. Results exceed maximum allowable contamination level: additional testine. If
a test conducted under this section for residual solvents or pesticides indicates that the
sample of harvested carmabis exceeds the maximum level of allowable contammation for
residual solvents or pesticides. as determined by the office pursuant to section 2423-G and
rules adopted pursuant to that section, the office shall:
A. Provide notification as reauired under subsection 3 and. if applicable, provide notice
to any registered careeiver. registered dispensarv or manufacturine facility from which
8 the harvested cannabis sample onRJnated;
B. Collect up to 3 additional samples of harvested caimabis from the registrant whose
sample exceeded the maximum level of allowable contamination for residual solvents
or pesticides and from any registrant from which the harvested cannabis sample
Pagel5-132LR0854(04)
COMMITTEE AMENDMENT
COMMHTEE AMENDMENT" r "toH.P. 1231,L.D. 1847
Cy'
originated from any location where a resistered careeiver. reeistered dispensarv 01
manufacturing facility conducts activity authorized under this chapteil
C. Restrict the transfer or sale of the batch of harvested cannabis that exceeded the
maximum level of allowable contamination for residual solvents or oesticides under
this subsection and may initiate a recall of any harvested cannabis from the batch that
may have already been sold or transferred; and
D. Conduct testing for residual solvents and pesticides on the additional sam&les
collected under naragraoh B at the expense of theregistrant,
If additional testing conducted under paragraph D indicates that any of the samples
collected under paragraph B exceed the maximum level of allowable contamination for
residual solvents or pesticides the office shall restrict the transfer or sale of all batches of
harvested cannabis m the possession of the registrant, initiate a recall of anv harvested
cannabis sold or transferred by the registrant from the batch or batches of harvested
caimabis tested and shall open an investieation into the conduct of the registrant,
5. Results exceed maximum allowable contamination level; administrative
penalty; violation types. The followine admimstrative penalties may am)lv:
A. ExceoL&r a_large_j^fflstered diseensary, a remstered_^c registered
disoensar/ or manufacturins facilifrv whose imtial test under this section indicates that
the sample of harvested cannabis exceeds the maximum level of allowable
contamination for residual solvents or pesticides may be subject to an_admmistrative
penalty for a minor registration violation under section 2430-1. subsection 1-A,
paragraph C: and
B. A repistered careeiver, registered dispensary or manufacturing facility that has a
sample collected under subsection 4. uaragraDh B that exceeds the maximum level of
allowable contamination for residual solvents or pesticides may be subject to an
admmistrative penalty for a major registration violation under section 2430-1.
subsection 1-A. oaraeraoh B.
If the office opens an investigation into the conduct of a registered caregiver. registered
dispensary or manufacturing. facilitv_under this section, eyidence of a violation of this
chapter or mles adopted pursuant to this chapter must be handled pursuant to section
2430-1.
PART B
See. B-l. 28-B MRSA §102-A, sub-§14-A is enacted to read:
14-A. Cannabis ore-roll. "Cannabis ore-roll" means cannabis flower, cannabis trim.
or a combmation of cannabis flower and cannabis trim that is rolled m rollmg papers,
6 cigarette papers or wraps, with or without a cardboard filter, and intended for smoking. A
carmabis pre-roll mav be infused with cannabis concentrate.
Sec. B-2. 28-B MRSA §102-A, sub-§64, as enacted by PL 2023,c. 679,Pt. B, §3,
is amended to read:
64. Testing facility. "Testing facility" means a facility licensed under this chapter to
develop, research and test cannabis? and carmabis products cmd other substances or a facility
registered in accordance with Title 22. chapter 558-C.
COMMITTEE AMENDMENT
COMMmEE AMENDMENT"/^ "toH.P. 1231, L.D. 1847
Sec. B-3. 28-B MRSA §605, sub-§4, as amended by PL 2023,c. 679, Ft. B,§120,
is further amended to read:
4. No subsequent further processing, manufacturing or alteration. Since the
performance of the prior testing under subsection 1, the cannabis or carmabis product has
not undergone any further processing, manufacturing or alteration fhat would result in an
increase in the concentration of any contaminants or factors identified in section 602,
subsection 1 or m any mles adopted by the office pursuant to that section. For the purposes
of^ this ^ "further orocessmg, masufacturing or alteration" does not include the
use of cannabis concentrate in the creation of an edible carmabis oroduct. exceot for testine
under section 602. subsection 1. naragraphF,
Sec. B-4. 28-B MRSA §1101, sub-§2, ^B-l is enacted to read:
B-l. Money credited to the fund may be expended by the office to fund research on
the public health impacts of cannabis use. includme. but not limited to. cannabis use
by individuals under 21 years of aee,
PART C
Sec. C-l. 36 MRSA §4921, sub-§7-A is enacted to read:
7-A. Cannabis pre-roll. "Cannabis pre-roll" has the same meamna as in Title 28-B.
section.l02-A. subsection 14-A.
Sec. C-2. 36 MRSA §4923, sub-§2-A is enacted to read:
2-A. Excise tax on cannabis pre-roll. Beeinnme January 1. 2028. a cultivation
facility licensee shall pay an excise tax pursuant to subsection 1 or 2 based upon the amQynt
per pound pr j&a^ within a
cannabis ure-roll.
PART D
Sec. D-l. Effective date. This Act takes effect January 1,2028;
Amend the bill by relettermg or renumbering any nonconsecutive Part letter or section
number to read consecutively.
SUMMARY
This amendment replaces the bill and changes the title.
Part A of the amendment makes the following changes to the Maine Medical Use of
CannabisAct.
1. It defines the terms "batch," "cannabis flower," "caimabis pre-roll," "cannabis trim,"
"large registered dispensary," "matrix," "remediation," "testing" and "THC," repeals and
replaces the definition of "canmbis testing facility" and amends the definitions of
"registrant" and "registrant agent."
2. It establishes a program for mandatory testing of harvested cannabis from a large
registered dispensary, which is defined in the amendment as a registered dispensary that
cultivates 2,000 square feet or more of mature plant canopy.
COMMITTEE AMENDMENT
COMMnTEE AMENDMENT'? "toH.P. 1231, L.D. 1847
3. It replaces previous authorization for caunabis testing facilities with a provision
establishing a cannabis testing facility registration and establishes additional requirements
necessary to obtain a registration certificate to operate a cannabis testing facility.
4. It includes cannabis testing facilities in the standard application process for a
registration certificate.
5. It adds certain requirements related to packaging for large registered dispensaries
who are required to conduct mandatory testing.
6, It provides that intentionally or knowingly failing to conduct a recall of harvested
carmabis or cannabis products when ordered to do so by fhe Department of Administrative
and Financial Services, Office ofCannabis Policy is a major registration violation affecting
public safety.
7. It establishes registration violations for exceeding the maximum level of allowable
contamination for residual solvents and pesticides in a sample of harvested cannabis tested
by the office as a part of an annual inspection for registered caregivers, registered
dispensaries who are not large registered dispensaries and manufacturing facilities.
8. It revises reporting and record-keeping requirements for large registered dispensaries
to require records retention for 6 years and to mandate that all large registered dispensaries
report all required inventory information m the statewide inventory tracking system
implemented and administered by the office. It also requires all other registrants to maintain
certain records related to the authorized conduct of the registrant and to keep those records
for a period of 4 years and to make those records available for inspection by the office upon
request.
9. It requires mandatory testing of all harvested carmabis from large registered
dispensaries for the presence of harmful contaminants and cannabinoid profiles and
specifies that the maximum size of a batch for mandatory testing by a large registered
dispensary is 44 pounds.
10. It requires reporting of mandatory test results of failed tests to the office and to the
large registered dispensary that submitted samples to a cannabis testing facility for testing.
11, It establishes sampling requirements and permits the office to take samples for audit
testing to verify mandatory test results and to ensure the quality, consistency and reliability
of the testing program.
12. It identifies the circumstances in which additional mandatory testing by the large
registered dispensary is not required before harvested cannabis is provided to a qualifying
patient.
13. It requires the office to conduct annual inspections for registered caregivers,
registered dispensaries, other than large registered dispensaries, and manufacturing
facilities, which must include the collection of a sample of harvested cannabis and requires
the office to test that sample for certain contaminants, including residual solvents and
pesticides.
Part B of the amendment makes the following changes to the Cannabis Legalization
Act.
1. It adds a definition of "cannabis pre-roll."
COMMITTEE AMENDMENT
COMMrTTEE AMENDMENT" r. ^toH.P, 1231,L.D. 1847
2. It amends the definition of "testing facility" to include a registered carmabis testing
facility under the JMEaine Medical Use of Caimabis Act,
3. It provides exemptions from final form testing for cannabis pre-rolls and edible
cannabis products.
4. It authorizes funds from the Adult Use Cannabis Public Health and Safety and
Municipal Opt-in Fund to be used for research on public health impacts of carmabis use,
includmg use by individuals who have not attained 21 years of age.
Part C of the amendment does the following.
1, It defines "caimabis pre-roll" for the purposes of the carmabis excise tax using the
same definition of "cannabis pre-roll" in the adult use carmabis program.
2, It establishes an excise tax for adult use cannabis pre-rolls as the amount per pound
or fraction thereof of adult use cannabis flower or adult use cannabis tnm used in a carmabis
pre-roll.
Part D of the amendment does the following.
1, It establishes an effective date of January 1, 2028.
FISCAL NOTE REQUIRED
(See attached)
Pagel9-132LR0854(04)
COMMITTEE AMENDMENT
Approved: 04/03/26 1-KI-
LD 1847 LR 854(04)
An Act to Institute Testing and Tracking of Medical Use Cannabis and Cannabis Products Similar to
Adult Use Cannabis and Cannabis Products, Dedicate a Portion of the Adult Use Cannabis Sales and
Excise Tax to Medical Use Cannabis Programs and Create a Study Group
Fiscal Note for Bill as Amended by Committee Amendment '^" / K-
Committee: Veterans and Legal Affairs
Fiscal Note Required: Yes
Fiscal Note
Projections Projections
FY 2025-26 FY 2026-27 FY 2027-28 FY 2028-29
Net Cost (Savings)
General Fund
Appropriations/Allocations
General Fund
Other Special Revenue Funds
Revenue
General Fund
Other Special Revenue Funds
$0
$0 $3,229,291 $1,480,488
$0 $0 $3,229,191 $1,479,188
$0 $0 $267,000 $534,000
$0
$0
$0
$0
($100)
$100
($1,300)
$300
Fiscal Detail and Notes
This bill establishes a mandatory testing program for harvested cannabis from large registered dispensaries, annual
inspections and sample testing requirements for other registrants, an electronic records submission portal and an
inventory tracking system, including changes to the excise tax treatment of certain cannabis products. This estimate is
based on an implementation model in which mandatory testing requirements are limited to large registered
dispensaries, while other registrants are subject primarily to inspection and sample-based oversight,
The Office ofCannabis Policy (OCP) within the Department of Administrative and Financial Services has indicated
that implementation of the provisions of this bill would require additional resources to support testing oversight, audit
activities, data management, and program administration, OCP would require ongoing General Fund appropriations of
$729,188 beginning in fiscal year 2027-28 for one Planning and Research Associate I position, one Public Relations
Representative position, one Senior Data Analyst position, 2 OCP Compliance Inspector positions and one Chemist II
position and associated All Other costs. The staffing levels reflect the need to support statewide inspection, sampling
and program administration activities, including registrants not subject to mandatory testing requirements,
OCP would also require a one-time General Fund appropriation of $2,500,000 in fiscal year 2027-28 to establish
electronic records submission capabilities to support reporting, data collection and oversight activities required by the
bill, and ongoing General Fund appropriations of $750,000 beginning in fiscal year 2028-29 for system maintenar
and support. These capabilities are intended to support data collection and oversight across the broader registrant
population,
LR0854(04) - Fiscal Note - Page 1 of 2
CC'Cti-1045)
In addition, OCP would require ongoing Other Special Revenue Funds allocations of $267,000 beginning in fiscal
year 2027-28 for the procurement and implementation of an electronic inventory tracking system applicable to a
subset of registrants. These costs are based on prior contract experience and are subject to change depending on the
results of the procurement process,
The bill would result in a revenue decrease to the General Fund of $100 in fiscal year 2027-28 and $1,300 in fiscal
year 2028-29 from increased prices leading to a reduction in quantity sold in the medical market with a partially
offsetting increase in sales of adult use cannabis. The bill would also result in a revenue increase to the Local
Government Fund and the Adult Use Cannabis Public Health and Safety Fund totaling $100 in fiscal year 2027-28 and
$300 in fiscal year 2028-29.
Implementation of the program is expected to occur over time due to rulemaking and a 12- to 18-month procurement
process for the inventory-tracking system. As a result, costs in fiscal year 2026-27 are expected to be limited to initial
implementation activities. The costs described above represent the estimated resources necessary to support full
program implementation beginning in fiscal year 2027-28,
The bill requires large registered dispensaries to pay certain costs associated with the inventory-tracking system,
testing, and audit activities. The State will continue to incur costs to administer the testing program, conduct
inspections and maintain oversight systems,
LR0854(04) - Fiscal Note - Page 2 of 2